This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aspirin and prevention of cognitive decline in postmenopausal women

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • the use of low dose aspirin as a measure to prevent cognitive decline in postmenopausal women has been investigated in the Women's Health Study
    • cohort study within both arms of the women's health study, a randomised, double blind, placebo controlled trial
    • 6377 women aged 65 or more were given low dose aspirin (100 mg on alternate days) or placebo for a mean of 9.6 years
    • the study authors concluded that the evidence did not support the use of low dose aspirin in postmenopausal women to prevent cognitive decline

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.